HK Stock MarketDetailed Quotes

MEDTIDE (03880)

Watchlist
  • 21.740
  • -0.360-1.63%
Market Closed May 29 16:07 CST
3.08BMarket Cap12.81P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MEDTIDE (03880) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Turnover
28.91%570.09M
28.52%253.77M
31.31%442.23M
21.23%197.46M
-4.01%336.77M
--162.88M
24.35%350.84M
--282.14M
Operating income
28.91%570.09M
28.52%253.77M
31.31%442.23M
21.23%197.46M
-4.01%336.77M
162.88M
24.35%350.84M
282.14M
Cost of sales
-8.33%-208.48M
-9.73%-98.81M
-22.89%-192.45M
-17.57%-90.05M
-4.56%-156.6M
---76.59M
-23.66%-149.77M
---121.12M
Operating expenses
-8.33%-208.48M
-9.73%-98.81M
-22.89%-192.45M
-17.57%-90.05M
-4.56%-156.6M
-76.59M
-23.66%-149.77M
-121.12M
Gross profit
44.77%361.61M
44.27%154.95M
38.63%249.77M
24.47%107.41M
-10.39%180.17M
86.29M
24.87%201.07M
161.02M
Selling expenses
-5.85%-44.98M
-7.96%-18.64M
-51.38%-42.49M
-29.43%-17.27M
-26.19%-28.07M
---13.34M
-10.96%-22.25M
---20.05M
Administrative expenses
-2.42%-75.18M
-5.82%-40.53M
-67.70%-73.41M
-75.70%-38.3M
-0.68%-43.77M
---21.8M
-14.93%-43.48M
---37.83M
Research and development expenses
-1.05%-29.05M
2.68%-12.65M
-24.21%-28.75M
-31.63%-13M
-10.10%-23.14M
---9.88M
-18.98%-21.02M
---17.67M
Revaluation surplus
122.14%18.46M
185.15%18.46M
-83.80%-83.39M
18.52%-21.68M
32.35%-45.37M
---26.61M
-196.72%-67.07M
---22.6M
-Changes in the fair value of other assets
122.14%18.46M
185.15%18.46M
-83.80%-83.39M
18.52%-21.68M
32.35%-45.37M
---26.61M
-196.72%-67.07M
---22.6M
Impairment and provision
-51.42%-1.39M
19.19%-678K
-52.67%-916K
-123.14%-839K
46.67%-600K
---376K
39.65%-1.13M
---1.86M
-Other impairment is provision
-51.42%-1.39M
19.19%-678K
-52.67%-916K
-123.14%-839K
46.67%-600K
---376K
39.65%-1.13M
---1.86M
Special items of operating profit
-61.71%22.51M
-64.21%15.28M
155.66%58.77M
148.68%42.71M
1.28%22.99M
--17.17M
-30.83%22.7M
--32.82M
Operating profit
216.60%251.98M
96.87%116.2M
27.95%79.59M
87.62%59.02M
-9.64%62.2M
31.46M
-26.63%68.84M
93.83M
Financing cost
-8.41%-1.24M
-2.16%-521K
-409.38%-1.14M
-289.31%-510K
82.51%-224K
---131K
71.12%-1.28M
---4.44M
Earning before tax
219.63%250.75M
97.70%115.68M
26.58%78.45M
86.77%58.51M
-8.26%61.98M
31.33M
-24.43%67.56M
89.39M
Tax
-73.14%-33.37M
-72.16%-13.68M
-47.45%-19.28M
-8.87%-7.95M
3.71%-13.07M
---7.3M
-48.96%-13.58M
---9.11M
After-tax profit from continuing operations
267.35%217.37M
101.71%102M
21.00%59.17M
110.43%50.57M
-9.40%48.91M
24.03M
-32.76%53.98M
80.28M
Earning after tax
267.35%217.37M
101.71%102M
21.00%59.17M
110.43%50.57M
-9.40%48.91M
24.03M
-32.76%53.98M
80.28M
Profit attributable to shareholders
267.35%217.37M
101.71%102M
21.00%59.17M
110.43%50.57M
-9.40%48.91M
24.03M
-32.76%53.98M
80.28M
Basic earnings per share
246.81%1.63
105.00%0.82
20.51%0.47
110.53%0.4
-27.78%0.39
0.19
-50.46%0.54
1.09
Diluted earnings per share
328.95%1.63
173.33%0.82
-2.56%0.38
57.89%0.3
-27.78%0.39
0.19
-49.06%0.54
1.06
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Auditor
--
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
Ernst & Young
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Turnover 28.91%570.09M28.52%253.77M31.31%442.23M21.23%197.46M-4.01%336.77M--162.88M24.35%350.84M--282.14M
Operating income 28.91%570.09M28.52%253.77M31.31%442.23M21.23%197.46M-4.01%336.77M162.88M24.35%350.84M282.14M
Cost of sales -8.33%-208.48M-9.73%-98.81M-22.89%-192.45M-17.57%-90.05M-4.56%-156.6M---76.59M-23.66%-149.77M---121.12M
Operating expenses -8.33%-208.48M-9.73%-98.81M-22.89%-192.45M-17.57%-90.05M-4.56%-156.6M-76.59M-23.66%-149.77M-121.12M
Gross profit 44.77%361.61M44.27%154.95M38.63%249.77M24.47%107.41M-10.39%180.17M86.29M24.87%201.07M161.02M
Selling expenses -5.85%-44.98M-7.96%-18.64M-51.38%-42.49M-29.43%-17.27M-26.19%-28.07M---13.34M-10.96%-22.25M---20.05M
Administrative expenses -2.42%-75.18M-5.82%-40.53M-67.70%-73.41M-75.70%-38.3M-0.68%-43.77M---21.8M-14.93%-43.48M---37.83M
Research and development expenses -1.05%-29.05M2.68%-12.65M-24.21%-28.75M-31.63%-13M-10.10%-23.14M---9.88M-18.98%-21.02M---17.67M
Revaluation surplus 122.14%18.46M185.15%18.46M-83.80%-83.39M18.52%-21.68M32.35%-45.37M---26.61M-196.72%-67.07M---22.6M
-Changes in the fair value of other assets 122.14%18.46M185.15%18.46M-83.80%-83.39M18.52%-21.68M32.35%-45.37M---26.61M-196.72%-67.07M---22.6M
Impairment and provision -51.42%-1.39M19.19%-678K-52.67%-916K-123.14%-839K46.67%-600K---376K39.65%-1.13M---1.86M
-Other impairment is provision -51.42%-1.39M19.19%-678K-52.67%-916K-123.14%-839K46.67%-600K---376K39.65%-1.13M---1.86M
Special items of operating profit -61.71%22.51M-64.21%15.28M155.66%58.77M148.68%42.71M1.28%22.99M--17.17M-30.83%22.7M--32.82M
Operating profit 216.60%251.98M96.87%116.2M27.95%79.59M87.62%59.02M-9.64%62.2M31.46M-26.63%68.84M93.83M
Financing cost -8.41%-1.24M-2.16%-521K-409.38%-1.14M-289.31%-510K82.51%-224K---131K71.12%-1.28M---4.44M
Earning before tax 219.63%250.75M97.70%115.68M26.58%78.45M86.77%58.51M-8.26%61.98M31.33M-24.43%67.56M89.39M
Tax -73.14%-33.37M-72.16%-13.68M-47.45%-19.28M-8.87%-7.95M3.71%-13.07M---7.3M-48.96%-13.58M---9.11M
After-tax profit from continuing operations 267.35%217.37M101.71%102M21.00%59.17M110.43%50.57M-9.40%48.91M24.03M-32.76%53.98M80.28M
Earning after tax 267.35%217.37M101.71%102M21.00%59.17M110.43%50.57M-9.40%48.91M24.03M-32.76%53.98M80.28M
Profit attributable to shareholders 267.35%217.37M101.71%102M21.00%59.17M110.43%50.57M-9.40%48.91M24.03M-32.76%53.98M80.28M
Basic earnings per share 246.81%1.63105.00%0.8220.51%0.47110.53%0.4-27.78%0.390.19-50.46%0.541.09
Diluted earnings per share 328.95%1.63173.33%0.82-2.56%0.3857.89%0.3-27.78%0.390.19-49.06%0.541.06
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIAS
Audit Opinions ----Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified Opinion
Auditor ----Ernst & Young--Ernst & Young--Ernst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 0.00%
Sample Name
Sample Code
 -6.41%
Sample Name
Sample Code
 -8.09%
4
PETROCHINA
00857
-9.10%
5
CNOOC
00883
-10.14%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +19.59%
Sample Name
Sample Code
 +18.95%
Sample Name
Sample Code
 +6.49%
4
Lotus Holdings
600186
+3.15%
5
China Greatwall Technology Group
000066
-0.17%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -